Alexandru Irimie
Cited by
Cited by
A comprehensive review on MAPK: a promising therapeutic target in cancer
C Braicu, M Buse, C Busuioc, R Drula, D Gulei, L Raduly, A Rusu, A Irimie, ...
Cancers 11 (10), 1618, 2019
Apoptosis in cancer: key molecular signaling pathways and therapy targets
C Burz, I Berindan-Neagoe, O Balacescu, A Irimie
Acta oncologica 48 (6), 811-821, 2009
CCAT2, a novel long non-coding RNA in breast cancer: expression study and clinical correlations
RS Redis, AM Sieuwerts, MP Look, O Tudoran, C Ivan, R Spizzo, X Zhang, ...
Oncotarget 4 (10), 1748, 2013
The relationship between the structure and biological actions of green tea catechins
C Braicu, MR Ladomery, VS Chedea, A Irimie, I Berindan-Neagoe
Food Chemistry 141 (3), 3282-3289, 2013
The clinical and biological significance of MIR-224 expression in colorectal cancer metastasis
H Ling, K Pickard, C Ivan, C Isella, M Ikuo, R Mitter, R Spizzo, MD Bullock, ...
Gut 65 (6), 977-989, 2016
The role of Nrf2 activity in cancer development and progression
AA Zimta, D Cenariu, A Irimie, L Magdo, SM Nabavi, AG Atanasov, ...
Cancers 11 (11), 1755, 2019
Isolation and characterization of hepatic cancer cells with stem-like properties from hepatocellular carcinoma.
C Tomuleasa, O Soritau, D Rus-Ciuca, T Pop, D Todea, O Mosteanu, ...
Journal of Gastrointestinal & Liver Diseases 19 (1), 2010
Gold nanoparticles conjugated with cisplatin/doxorubicin/capecitabine lower the chemoresistance of hepatocellular carcinoma-derived cancer cells.
C Tomuleasa, O Soritau, A Orza, M Dudea, B Petrushev, O Mosteanu, ...
Journal of Gastrointestinal & Liver Diseases 21 (2), 2012
Multiple Primary Malignancies-Epidemiological Analysis at a Single Tertiary Institution.
A Irimie, P Achimas-Cadariu, C Burz, E Puscas
Journal of Gastrointestinal & Liver Diseases 19 (1), 2010
Epigallocatechin-3-Gallate (EGCG) inhibits cell proliferation and migratory behaviour of triple negative breast cancer cells
C Braicu, CD Gherman, A Irimie, I Berindan-Neagoe
Journal of Nanoscience and Nanotechnology 13 (1), 632-637, 2013
The function of non-coding RNAs in lung cancer tumorigenesis
C Braicu, AA Zimta, A Harangus, I Iurca, A Irimie, O Coza, ...
Cancers 11 (5), 605, 2019
The impact of miRNA in colorectal cancer progression and its liver metastases
O Balacescu, D Sur, C Cainap, S Visan, D Cruceriu, R Manzat-Saplacan, ...
International journal of molecular sciences 19 (12), 3711, 2018
Exosome-carried microRNA-375 inhibits cell progression and dissemination via Bcl-2 blocking in colon cancer
F Zaharie, MS Muresan, B Petrushev, C Berce, GA Gafencu, S Selicean, ...
J Gastrointestin Liver Dis 24 (4), 435-443, 2015
Dietary intervention by phytochemicals and their role in modulating coding and non-coding genes in cancer
L Budisan, D Gulei, OM Zanoaga, AI Irimie, S Chira, C Braicu, ...
International Journal of Molecular Sciences 18 (6), 1178, 2017
A comprehensive picture of extracellular vesicles and their contents. Molecular transfer to cancer cells
A Jurj, O Zanoaga, C Braicu, V Lazar, C Tomuleasa, A Irimie, ...
Cancers 12 (2), 298, 2020
Current insights into oral cancer epigenetics
AI Irimie, C Ciocan, D Gulei, N Mehterov, AG Atanasov, D Dudea, ...
International journal of molecular sciences 19 (3), 670, 2018
Epigallocatechin-3-gallate suppresses cell proliferation and promotes apoptosis and autophagy in oral cancer SSC-4 cells
AI Irimie, C Braicu, O Zanoaga, V Pileczki, C Gherman, ...
OncoTargets and therapy, 461-470, 2015
The relationships between biological activities and structure of flavan-3-ols
C Braicu, V Pilecki, O Balacescu, A Irimie, IB Neagoe
International journal of molecular sciences 12 (12), 9342-9353, 2011
The role of Skp2 and its substrate CDKN1B (p27) in colorectal cancer.
OV Bochis, A Irimie, M Pichler, I Berindan-Neagoe
Journal of Gastrointestinal & Liver Diseases 24 (2), 2015
Nanopharmacology in translational hematology and oncology
C Tomuleasa, C Braicu, A Irimie, L Craciun, I Berindan-Neagoe
International Journal of Nanomedicine 9, 3465, 2014
The system can't perform the operation now. Try again later.
Articles 1–20